Triptolide and its analogs have been shown to inhibit NF-κB signaling, which in pancreatic cancer cells results in elevated oxidative stress, reduced Bcl-2 expression, and activation of mitochondrial apoptosis pathways (100). This evidence concerns the gene BCL2 and familial pancreatic carcinoma.